Urvogelbio is a life science company developing exosome-based applications in the biomarker and therapeutic space for CNS and oncology therapeutic areas. Currently, we are developing a portfolio of diagnostic tests for Alzheimer (AD), Multiple sclerosis (MS), stroke diagnostics, using neuronal exosome profiling and cell-free DNA. Novel exosomal biotherapeutics are being developed by using mesenchymal stem cells, cord blood and amniotic fluids.